share_log

盘中速览 | 三大指数延续跌势,科指跌超2%;苹果概念股、医药股集体走弱,舜宇光学科技跌超8%,药明生物跌近5%

Intraday Overview | The three major indices continued to decline, with the Tech Index falling more than 2%; Apple concept stocks and pharmaceutical stocks collectively weakened, Shunyu Optical Technology fell more than 8%, and Pharmaceutical Biotech fell

Futu News ·  Jan 31 10:35

Futu News reported on January 31 that the three major indices continued to decline. As of press release, the Hang Seng Index had fallen 1.36%, the Science Index had fallen 2.47%, and the National Index had fallen 1.54%.

On the sector side, TechNet stocks have collectively weakened, with Xiaomi falling nearly 4%, Meituan falling nearly 3%, Kuaishou falling more than 2%, and Ali, JD, and Baidu falling more than 1%.

Domestic housing stocks continued to decline, with Country Garden falling more than 3%, Longhu Group, Xincheng Development, and Sunac China falling nearly 2%, and China Resources Land falling more than 1%.

Apple concept stocks fell, with Shunyu Optical Technology falling more than 8%, Gaowei Electronics falling more than 6%, Ruisheng Technology falling more than 4%, and BYD Electronics falling more than 1%.

Pharmaceutical stocks weakened collectively, with Pharmacovigilance falling more than 5%, Pharmaceutical Biotech falling nearly 5%, BeiGene Shenzhou and Kingsry Biotech falling more than 2%, and Kangfang Biotech falling more than 1%.

Auto stock performance was weak, with Zero Sport and NIO falling more than 5%, Xiaopeng Motors falling more than 4%, Great Wall Motors falling more than 3%, and BYD shares falling more than 1%.

In terms of individual stocks,$SUNNY OPTICAL (02382.HK)$The profit margin dropped more than 8% after that, and net profit is expected to fall by more than 50% year on year last year.

$GANFENGLITHIUM (01772.HK)$It fell more than 6%. Net profit due to mother is expected to be 4.2 billion to 6.2 billion yuan in 2023, a year-on-year decrease of about 69.76%-79.52%.

Editor/Corrine

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment